Matthew Whitlock

Clinical Assistant Professor, Medicine - Cardiovascular Medicine Clinical Assistant Professor, Medicine - Cardiovascular Medicine

Clinical Focus

Cardiovascular Disease

Academic Appointments

Clinical Assistant Professor, Medicine - Cardiovascular Medicine
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
Member, Cardiovascular Institute

Professional Education

Residency: Oregon Health and Science University Internal Medicine Residency (2008) OR
Fellowship: Wake Forest Baptist Medical Center (2015) NC
Board Certification: American Board of Internal Medicine, Cardiovascular Disease (2011)
Fellowship: Vanderbilt University Medical Center Cardiovasular Fellowship (2011) TN
Medical Education: University of North Carolina School of Medicine (2005) NC

Contact

Clinical Contact Tel: 831-649-9330

Clinical Stanford Cardiovascular Clinic 300 Pasteur Dr Rm A21 MC 5319 Stanford CA 94305 Tel: (650) 723-6459 Fax: (650) 724-1444
Clinical VA Palo Alto Health Care System 3801 Miranda Ave Palo Alto CA 94304 Tel: (650) 493-5000 Fax: (650) 614-8473

All Publications

Profiles With Related Publications

close
Hans-Christoph Becker, MD, FSABI, FSCCT

Clinical Professor, Radiology
Clinical Focus
Diagnostic Radiology
Research Interests
Myocardial bridges (MB) with associated upfront atherosclerotic lesions are common findings on coronary computed tomography angiography (CTA). Abnormal septal wall motion in exercise echocardiography (EE) may to be associated with MB. Intravascular ultrasound (IVUS) is considered the gold standard for the detection of MB. We investigate whether CTA is comparable to IVUS for the assessment of MB and upstream plaques in symptomatic patients with suspicion for MB raised by EE.

243 Total Publications
close
Sujatha Buddhe

Clinical Associate Professor, Pediatrics - Cardiology Clinical Associate Professor (By courtesy), Radiology - Pediatric Radiology
Clinical Focus
Pediatric Cardiology

42 Total Publications
close
Christopher Cheng

Adjunct Professor, Surgery - Vascular Surgery

64 Total Publications
close
William Fearon, MD

Professor of Medicine (Cardiovascular Medicine)
Clinical Focus
Interventional Cardiology, Transcatheter aortic valve replacement, TAVR, Percutaneous Coronary Intervention, Aortic Stenosis, Coronary Artery Disease, Coronary Physiology
Research Interests
Dr. Fearon's general research interest is coronary physiology. In particular, he is investigating invasive methods for evaluating the coronary microcirculation. His research is currently funded by an NIH R01 Award.

498 Total Publications
close
Jeffrey A. Feinstein, MD, MPH

Dunlevie Family Professor of Pulmonary Vascular Disease and Professor, by courtesy, of Bioengineering
Clinical Focus
Pediatric Cardiology, Pulmonary Hypertension, Pulmonary Vascular Disease, Pulmonary Vascular Abnormalities, Congenital Heart Defects, Alagille Syndrome, Biomechanical Engineering / Bioengineering
Research Interests
Research interests include (1) computer simulation and modeling of cardiovascular physiology with specific attention paid to congenital heart disease and its treatment, (2) the evaluation and treatment of pulmonary hypertension/pulmonary vascular diseases, and (3) development and testing of medical devices/therapies for the treatment of congenital heart disease and pulmonary vascular diseases.

189 Total Publications
close
Dominik Fleischmann

Professor of Radiology (Cardiovascular Imaging)
Clinical Focus
Cardiovacular Imaging, Diagnostic Radiology, Radiology
Research Interests
Non-invasive Cardiovascular Imaging
Image Post-processing
Contrast Medium Dynamics

295 Total Publications
close
Francois Haddad

Clinical Professor, Medicine - Cardiovascular Medicine
Clinical Focus
Cardiology, RIght Heart Failure, Pulmonary Hypertension, Hypertensive Heart Disease, Heart Failure with preserved ejection fraction, Advanced heart failure, Heart Transplantation, Unexplained Dyspnea, Mechanical Cardiac Support

327 Total Publications
close
Paul Heidenreich, MD

Professor of Medicine (Cardiovascular)
Clinical Focus
Echocardiography, Cardiovascular Disease
Research Interests
My research interests include

1) The cost-effectiveness of new cardiovascular technologies.
Example: tests to screen asymptomatic patients for left ventricular systolic dysfunction.

2) Interventions to improve the quality of care of patients with heart disease. Examples: include clinical reminders and home monitoring.

3) Outcomes research using existing clinical and administrative datasets.

4) Use of echocardiography to predict prognosis (e.g. diastolic dysfunction).

919 Total Publications
close
Mark Hlatky, MD

Professor of Health Policy, of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health
Research Interests
My main research work is in "outcomes research", especially examining the field of cardiovascular medicine. Particular areas of interest are the integration of economic and quality of life data into randomized clinical trials, evidence-based medicine, decision models, and cost-effectiveness analysis. I am also interested in the application of novel genetic, biomarker, and imaging tests to assess risk and guide clinical management of coronary artery disease.

419 Total Publications
close
Bob Hu

Adjunct Professor, Electrical Engineering Professor, Electrical Engineering

91 Total Publications
close
Daniel Katz

Instructor, Medicine - Cardiovascular Medicine
Clinical Focus
Cardiovascular Disease, Cardiac Transplantation, Heart-Assist Devices, Heart Failure

29 Total Publications
close
David J. Maron

C. F. Rehnborg Professor and Professor of Medicine (Stanford Prevention Research Center)
Clinical Focus
Cardiovascular Disease, Coronary Artery Disease, Angina, High Cholesterol, Familial Hypercholesterolemia, Coronary Artery Calcification, Primary Prevention, Secondary Prevention, Chest Pain
Research Interests
Dr. Maron is the Co-Chair and Principal Investigator of the ISCHEMIA trial, and Co-Chair of the ISCHEMIA-CKD trial. These large, international, NIH-funded studies will determine whether an initial invasive strategy of cardiac catheterization and revascularization plus optimal medical therapy will reduce cardiovascular events in patients with and without chronic kidney disease and at least moderate ischemia compared to an initial conservative strategy of optimal medical therapy alone.

210 Total Publications